ReviewBehavioral sciences (Basel, Switzerland)2026
AI in Psychotherapy: Opportunities and Risks.
Review in Behavioral sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article examines the emerging role of artificial intelligence in mental health contexts, with a particular focus on psychotherapy and the risks associated with deploying large language models (LLMs) in sensitive clinical domains. It aims to provide a broad review of current literature, highlighting key risks of general-purpose artificial intelligence (AI) systems, while also exploring the potential of clinically oriented LLMs for therapist training, supervision, and professional development. It discusses several key concerns, including AI-related psychosis, the development of parasocial attachments, and the growing number of crisis-related interactions users have with general-purpose AI models. These challenges raise important questions about the safety, reliability, and ethical management of AI systems when individuals seek support during periods of psychological crisis. Beyond identifying these risks, the article explores the potential of clinical LLMs specifically designed for mental health applications. In particular, AI can serve as a tool for therapists' training, supervision, and professional development, offering simulated clinical scenarios, structured feedback, and support for reflective practice. The article concludes by outlining key directions for the responsible development of therapeutic AI. These include the importance of human oversight, the use of specialized and clinically informed training datasets, advances in model fine-tuning and safety alignment, and the establishment of clear professional guidelines and regulatory frameworks. Together, these developments may help ensure that AI technologies are integrated into mental healthcare in ways that prioritize safety, ethical practice, and the continued central role of human clinicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.